Literature DB >> 10829360

The current management of cystic fibrosis.

C M Lees1, R L Smyth.   

Abstract

Cystic fibrosis (CF) is one of the commonest lethal inherited conditions among Caucasians. It affects multiple organ systems and exhibits a range of clinical problems of varying severity. Life expectancy has improved in recent years as treatment regimes have become more intensive, but current treatments are expensive, often time consuming and may affect quality of life. This review summarises the treatments currently used in the management of patients with CF, and the evidence for these.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10829360

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  4 in total

Review 1.  Autonomic dysfunction in cystic fibrosis.

Authors:  A Mirakhur; M J Walshaw
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients.

Authors:  Stefanie Hennig; Timothy H Waterhouse; Scott C Bell; Megan France; Claire E Wainwright; Hugh Miller; Bruce G Charles; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2006-10-30       Impact factor: 4.335

3.  Hospitalisation costs of cystic fibrosis.

Authors:  Jonas Schreyögg; Helge Hollmeyer; Miriam Bluemel; Doris Staab; Reinhard Busse
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers.

Authors:  J B Bulitta; S B Duffull; M Kinzig-Schippers; U Holzgrabe; U Stephan; G L Drusano; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  2007-05-07       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.